Wednesday, 24 September 2014

HMG-coenzyme A reductase inhibition, type 2 diabetes, and bodyweight

Evidence from genetic analysis and randomised trials (The Lancet)

Patient Empowerment Programme (PEP) in Primary Care Reduced All-cause Mortality and Cardiovascular Diseases in Patients with Type 2 Diabetes Mellitus

Enrolment in PEP was associated with reduced all-cause mortality and first CVD events among T2DM patients (Diabetes, Obesity and Metabolism)

Relationships between patient activation, disease-specific knowledge and health outcomes among people with diabetes; a survey study

Among people with diabetes, patient activation level was especially related to disease-specific knowledge and less with health-related behavior and outcomes. The PAM might therefore especially be an useful instrument for clinical practice to identify patients most in need for diabetes education (BMC Health Services Research)

No comments:

Post a Comment